The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer
Open accessAbstract
The targeted delivery of a drug should result in enhanced therapeutic efficacy with low to minimal side effects. This is a widely accepted concept, but limited in application due to lack of available technologies and process of validation. Biomedical nanotechnology can play an important role in this respect. Biomedical nanotechnology is a burgeoning field with myriads of opportunities and possibilities for advancing medical science and disease treatment. Cancer nanotechnology (1–100 nm size range) is expected to change the very foundations of cancer treatment, diagnosis and detection. Nanomaterials, especially gold nanoparticles (AuNPs) have unique physicochemical properties, such as ultra small size, large surface area to mass ratio, and high surface reactivity, presence of surface plasmon resonance (SPR) bands, biocompatibility and ease of surface functionalization. In this review, we will discuss how the unique physico-chemical properties of gold nanoparticles may be utilized for targeted drug delivery in pancreatic cancer leading to increased efficacy of traditional chemotherapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Daniel, M.-C., & Astruc, D. (2004) · Chemical Reviews · doi:10.1021/cr030698+ · Cited by 12,446
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,781
Kelly, K. L., Coronado, E., Zhao, L. L., & Schatz, G. C. (2003) · The Journal of Physical Chemistry B · doi:10.1021/jp026731y · Cited by 10,594
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions
FRENS, G. (1973) · Nature Physical Science · doi:10.1038/physci241020a0 · Cited by 8,336
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
A study of the nucleation and growth processes in the synthesis of colloidal gold
Turkevich, J., Stevenson, P. C., & Hillier, J. (1951) · Discussions of the Faraday Society · doi:10.1039/df9511100055 · Cited by 7,792
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Synthesis of thiol-derivatised gold nanoparticles in a two-phase Liquid–Liquid system
Brust, M., Walker, M., Bethell, D., Schiffrin, D. J., & Whyman, R. (1994) · J. Chem. Soc., Chem. Commun. · doi:10.1039/c39940000801 · Cited by 6,707
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,894
Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods
Huang, X., El-Sayed, I. H., Qian, W., & El-Sayed, M. A. (2006) · Journal of the American Chemical Society · doi:10.1021/ja057254a · Cited by 5,436
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., & Thun, M. J. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.1.8 · Cited by 3,984
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Link, S., & El-Sayed, M. A. (1999) · The Journal of Physical Chemistry B · doi:10.1021/jp9917648 · Cited by 3,896
Moore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J. R., Gallinger, S., Au, H. J., Murawa, P., Walde, D., Wolff, R. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9525 · Cited by 3,848
Cancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1609 · Cited by 3,313
Anisotropic Metal Nanoparticles: Synthesis, Assembly, and Optical Applications
Murphy, C. J., Sau, T. K., Gole, A. M., Orendorff, C. J., Gao, J., Gou, L., Hunyadi, S. E., & Li, T. (2005) · The Journal of Physical Chemistry B · doi:10.1021/jp0516846 · Cited by 3,085
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Plasmonic photothermal therapy (PPTT) using gold nanoparticles
Huang, X., Jain, P. K., El-Sayed, I. H., & El-Sayed, M. A. (2008) · Lasers in Medical Science · doi:10.1007/s10103-007-0470-x · Cited by 2,376
Link, S., & El-Sayed, M. A. (2000) · International Reviews in Physical Chemistry · doi:10.1080/01442350050034180 · Cited by 2,374
Gold, P., & Freedman, S. O. (1965) · The Journal of Experimental Medicine · doi:10.1084/jem.121.3.439 · Cited by 2,310
Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum
Ahmad, A., Mukherjee, P., Senapati, S., Mandal, D., Khan, M. I., Kumar, R., & Sastry, M. (2003) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(02)00174-1 · Cited by 1,976
Self-citationEl-Sayed, I. H., Huang, X., & El-Sayed, M. A. (2005) · Nano Letters · doi:10.1021/nl050074e · Cited by 1,919
Size‐Dependent Cytotoxicity of Gold Nanoparticles
Pan, Y., Neuss, S., Leifert, A., Fischler, M., Wen, F., Simon, U., Schmid, G., Brandau, W., & Jahnen‐Dechent, W. (2007) · Small · doi:10.1002/smll.200700378 · Cited by 1,878
Gold Nanoparticles in Biology: Beyond Toxicity to Cellular Imaging
Murphy, C. J., Gole, A. M., Stone, J. W., Sisco, P. N., Alkilany, A. M., Goldsmith, E. C., & Baxter, S. C. (2008) · Accounts of Chemical Research · doi:10.1021/ar800035u · Cited by 1,807
Immunotargeted Nanoshells for Integrated Cancer Imaging and Therapy
Loo, C., Lowery, A., Halas, N., West, J., & Drezek, R. (2005) · Nano Letters · doi:10.1021/nl050127s · Cited by 1,792
Shukla, R., Bansal, V., Chaudhary, M., Basu, A., Bhonde, R. R., & Sastry, M. (2005) · Langmuir · doi:10.1021/la0513712 · Cited by 1,687
The use of gold nanoparticles to enhance radiotherapy in mice
Hainfeld, J. F., Slatkin, D. N., & Smilowitz, H. M. (2004) · Physics in Medicine and Biology · doi:10.1088/0031-9155/49/18/n03 · Cited by 1,638
Tyrosine Kinase Inhibition: An Approach to Drug Development
Levitzki, A., & Gazit, A. (1995) · Science · doi:10.1126/science.7892601 · Cited by 1,635
Nanoshell-Enabled Photothermal Cancer Therapy: Impending Clinical Impact
Lal, S., Clare, S. E., & Halas, N. J. (2008) · Accounts of Chemical Research · doi:10.1021/ar800150g · Cited by 1,625
Biological synthesis of triangular gold nanoprisms
Shankar, S. S., Rai, A., Ankamwar, B., Singh, A., Ahmad, A., & Sastry, M. (2004) · Nature Materials · doi:10.1038/nmat1152 · Cited by 1,614
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,606
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
Seidman, A. D., Hudis, C. A., Pierri, M. K., Shak, S., Paton, V. E., Ashby, M. A., Murphy, M., Stewart, S. J., & Keefe, D. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1215 · Cited by 1,563
Mukherjee, P., Ahmad, A., Mandal, D., Senapati, S., Sainkar, S. R., Khan, M. I., Parishcha, R., Ajaykumar, P. V., Alam, M., Kumar, R., et al. (2001) · Nano Letters · doi:10.1021/nl0155274 · Cited by 1,438
Self-citationELSAYED, I., HUANG, X., & ELSAYED, M. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.07.035 · Cited by 1,354
Gold nanoparticles: a new X-ray contrast agent
Hainfeld, J. F., Slatkin, D. N., Focella, T. M., & Smilowitz, H. M. (2006) · The British Journal of Radiology · doi:10.1259/bjr/13169882 · Cited by 1,351
Dahl, J. A., Maddux, B. L. S., & Hutchison, J. E. (2007) · Chemical Reviews · doi:10.1021/cr050943k · Cited by 1,284
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery
Paciotti, G. F., Myer, L., Weinreich, D., Goia, D., Pavel, N., McLaughlin, R. E., & Tamarkin, L. (2004) · Drug Delivery · doi:10.1080/10717540490433895 · Cited by 1,185
Nanoshell-Enabled Photonics-Based Imaging and Therapy of Cancer
Loo, C., Lin, A., Hirsch, L., Lee, M.-H., Barton, J., Halas, N., West, J., & Drezek, R. (2004) · Technology in Cancer Research & Treatment · doi:10.1177/153303460400300104 · Cited by 1,160
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
Grandis, J. R., Melhem, M. F., Gooding, W. E., Day, R., Holst, V. A., Wagener, M. M., Drenning, S. D., & Tweardy, D. J. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.11.824 · Cited by 1,113
Computationally Guided Photothermal Tumor Therapy Using Long-Circulating Gold Nanorod Antennas
von Maltzahn, G., Park, J.-H., Agrawal, A., Bandaru, N. K., Das, S. K., Sailor, M. J., & Bhatia, S. N. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4242 · Cited by 1,051
Biological properties of “naked” metal nanoparticles☆
BHATTACHARYA, R., & MUKHERJEE, P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.013 · Cited by 917
Self-citationMukherjee, P., Ahmad, A., Mandal, D., Senapati, S., Sainkar, S. R., Khan, M. I., Ramani, R., Parischa, R., Ajayakumar, P. V., Alam, M., et al. (2001) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20011001)40:19<3585::aid-anie3585>3.0.co;2-k · Cited by 841
Self-citationA Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase
Fry, D. W., Kraker, A. J., McMichael, A., Ambroso, L. A., Nelson, J. M., Leopold, W. R., Connors, R. W., & Bridges, A. J. (1994) · Science · doi:10.1126/science.8066447 · Cited by 806
(1997) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(97)89864-3 · Cited by 750
Maitra, A., & Hruban, R. H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154305 · Cited by 707
Singaravelu, G., Arockiamary, J. S., Kumar, V. G., & Govindaraju, K. (2007) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2007.01.010 · Cited by 701
Extracellular Synthesis of Gold Nanoparticles by the Fungus Fusarium oxysporum
Mukherjee, P., Senapati, S., Mandal, D., Ahmad, A., Khan, M. I., Kumar, R., & Sastry, M. (2002) · ChemBioChem · doi:10.1002/1439-7633(20020503)3:5<461::aid-cbic461>3.0.co;2-x · Cited by 672
Self-citationAcute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles
Cho, W.-S., Cho, M., Jeong, J., Choi, M., Cho, H.-Y., Han, B. S., Kim, S. H., Kim, H. O., Lim, Y. T., Chung, B. H., et al. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.12.023 · Cited by 651
Tyrosine kinase – Role and significance in Cancer
Paul, M. K., & Mukhopadhyay, A. K. (2004) · International Journal of Medical Sciences · doi:10.7150/ijms.1.101 · Cited by 624
Specific Antigen in Serum of Patients with Colon Carcinoma
Koprowski, H., Herlyn, M., Steplewski, Z., & Sears, H. F. (1981) · Science · doi:10.1126/science.6163212 · Cited by 591
ErbB receptors: from oncogenes to targeted cancer therapies
Zhang, H., Berezov, A., Wang, Q., Zhang, G., Drebin, J., Murali, R., & Greene, M. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32278 · Cited by 574
Heinemann, V., Hertel, L. W., Grindey, G. B., & Plunkett, W. K. (1988) · PubMed · Cited by 504
Polymeric anticancer drugs with pH-controlled activation
Ulbrich, K. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.040 · Cited by 494
Korc, M., Chandrasekar, B., Yamanaka, Y., Friess, H., Buchier, M., & Beger, H. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116001 · Cited by 492
Localization of gene for human p53 tumour antigen to band 17p13
Isobe, M., Emanuel, B. S., Givol, D., Oren, M., & Croce, C. M. (1986) · Nature · doi:10.1038/320084a0 · Cited by 485
Emerging implications of nanotechnology on cancer diagnostics and therapeutics
Cuenca, A. G., Jiang, H., Hochwald, S. N., Delano, M., Cance, W. G., & Grobmyer, S. R. (2006) · Cancer · doi:10.1002/cncr.22035 · Cited by 475
Antiangiogenic Properties of Gold Nanoparticles
Mukherjee, P., Bhattacharya, R., Wang, P., Wang, L., Basu, S., Nagy, J. A., Atala, A., Mukhopadhyay, D., & Soker, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2482 · Cited by 468
Self-citationDevelopment of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy
Yang, X. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00134-7 · Cited by 463
Yamanaka, Y., Frieß, H., Kobrin, M. S., Büchler, M. W., Hg, B., & Korc, M. (1993) · PubMed · Cited by 461
Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors.
Sato, J. D., Kawamoto, T., Le, A. D., Mendelsohn, J. M., Polikoff, J., & SATO, G. H. (1983) · PubMed · Cited by 458
Herbst, R. S., & Shin, D. M. (2002) · Cancer · doi:10.1002/cncr.10372 · Cited by 446
Dual role of the Smad4/DPC4 tumor suppressor in TGFβ-inducible transcriptional complexes
Liu, F., Pouponnot, C., & Massagué, J. (1997) · Genes & Development · doi:10.1101/gad.11.23.3157 · Cited by 445
The Price Tag on Progress — Chemotherapy for Colorectal Cancer
Schrag, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048143 · Cited by 436
Huang, X., Jain, P. K., El‐Sayed, I. H., & El‐Sayed, M. A. (2006) · Photochemistry and Photobiology · doi:10.1562/2005-12-14-ra-754 · Cited by 427
Bruns, C. J., Harbison, M. T., Davis, D. W., Portera, C. A., Tsan, R. Z., McConkey, D. J., Evans, D. B., Abbruzzese, J. L., Hicklin, D. J., & Radinsky, R. (2000) · PubMed · Cited by 422
Nampt: linking NAD biology, metabolism and cancer
Garten, A., Petzold, S., Körner, A., Imai, S.-I., & Kiess, W. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.10.004 · Cited by 398
Arteaga, C. L. (2001) · PubMed · Cited by 397
Development trends for monoclonal antibody cancer therapeutics
Reichert, J. M., & Valge-Archer, V. E. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2241 · Cited by 389
Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): A review
Malet-Martino, M., & Martino, R. (2002) · The Oncologist · doi:10.1634/theoncologist.7-4-288 · Cited by 382
Kattumuri, V., Katti, K., Bhaskaran, S., Boote, E. J., Casteel, S. W., Fent, G. M., Robertson, D. J., Chandrasekhar, M., Kannan, R., & Katti, K. V. (2007) · Small · doi:10.1002/smll.200600427 · Cited by 380
Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
Patra, C. R., Bhattacharya, R., Wang, E., Katarya, A., Lau, J. S., Dutta, S., Muders, M., Wang, S., Buhrow, S. A., Safgren, S. L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6102 · Cited by 371
Self-citationBerger, A. C., Garcia, M., Hoffman, J. P., Regine, W. F., Abrams, R. A., Safran, H., Konski, A., Benson, A. B., MacDonald, J., & Willett, C. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6288 · Cited by 371
Prewett, M. C., Hooper, A. T., Bassi, R., Ellis, L. M., Waksal, H. W., & Hicklin, D. J. (2002) · PubMed · Cited by 352
Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy.
Mendelsohn, J. M. (1997) · PubMed · Cited by 344
The epidermal growth factor receptor as a target for cancer therapy.
Mendelsohn, J. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080003 · Cited by 330
Role of Poly(amidoamine) Dendrimers for Preparing Nanoparticles of Gold, Platinum, and Silver
Esumi, K., Suzuki, A., Yamahira, A., & Torigoe, K. (2000) · Langmuir · doi:10.1021/la991291w · Cited by 326
Han, R., Yang, Y. M., Dietrich, J., Luebke, A., Mayer-Pröschel, M., & Noble, M. (2008) · Journal of Biology · doi:10.1186/jbiol69 · Cited by 316
Orthotopic models of cancer for preclinical drug evaluation
Bibby, M. C. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.021 · Cited by 315
Radiolytic Control of the Size of Colloidal Gold Nanoparticles
Henglein, A., & Meisel, D. (1998) · Langmuir · doi:10.1021/la981278w · Cited by 313
(2001) · PubMed · Cited by 309
ARTEAGA, C. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70085-7 · Cited by 302
Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene.
Matlashewski, G., Lamb, P., Pim, D., Peacock, J., Crawford, L., & Benchimol, S. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02287.x · Cited by 299
Shin, D. M., Donato, N. J., Perez-Soler, R., Shin, H. J. C., Wu, J. Y., Zhang, P. G. Y., Lawhorn, K., Khuri, F. R., Glisson, B. S., Myers, J. N., et al. (2001) · PubMed · Cited by 298
Oncogenic KRAS Activates Hedgehog Signaling Pathway in Pancreatic Cancer Cells
Ji, Z., Mei, F. C., Xie, J., & Cheng, X. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611089200 · Cited by 296
Burris, H. A. (2004) · The Oncologist · doi:10.1634/theoncologist.9-suppl_3-10 · Cited by 295
Eck, W., Craig, G., Sigdel, A., Ritter, G., Old, L. J., Tang, L., Brennan, M. F., Allen, P. J., & Mason, M. D. (2008) · ACS Nano · doi:10.1021/nn800429d · Cited by 280
Medical uses of gold compounds: Past, present and future
Pricker, S. P. (1996) · Gold Bulletin · doi:10.1007/bf03215464 · Cited by 279
EGFR Targeting of Solid Tumors
Rocha-Lima, C. M., Soares, H. P., Raez, L. E., & Singal, R. (2007) · Cancer Control · doi:10.1177/107327480701400313 · Cited by 274
Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.
Kovalenko, M. V., Gazit, A., Böhmer, A., Rorsman, C., Rönnstrand, L., Heldin, C., Waltenberger, J. L., Böhmer, F., & Levitzki, A. (1994) · PubMed · Cited by 269
Radiofrequency Ablation in 447 Complex Unresectable Liver Tumors: Lessons Learned
Bleicher, R. J., Allegra, D. P., Nora, D. T., Wood, T. F., Foshag, L. J., & Bilchik, A. J. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.03.018 · Cited by 267
Mandal, T. K., Fleming, M. S., & Walt, D. R. (2002) · Nano Letters · doi:10.1021/nl015582c · Cited by 264
Gannon, C. J., Patra, C. R., Bhattacharya, R., Mukherjee, P., & Curley, S. A. (2008) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-6-2 · Cited by 261
Self-citationPancreatic Adenocarcinoma: The Actual 5-Year Survivors
Ferrone, C. R., Brennan, M. F., Gonen, M., Coit, D. G., Fong, Y., Chung, S., Tang, L., Klimstra, D., & Allen, P. J. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0384-8 · Cited by 251
Role of Smad4 (DPC4) inactivation in human cancer
Miyaki, M., & Kuroki, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01066-0 · Cited by 242
Epidermal growth factor receptor biology (IMC-C225)
Kim, E. S., Khuri, F. R., & Herbst, R. S. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200111000-00014 · Cited by 242
Hess, V., Glimelius, B., Grawe, P., Dietrich, D., Bodoky, G., Ruhstaller, T., Bajetta, E., Saletti, P., Figer, A., Scheithauer, W., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70001-9 · Cited by 239
Arteaga, C. L. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.35642 · Cited by 228
A Dynamic View of Self-Assembled Monolayers
Badia, A., Lennox, R. B., & Reven, L. (2000) · Accounts of Chemical Research · doi:10.1021/ar9702841 · Cited by 222
Jaffee, E. M., Hruban, R. H., Canto, M., & Kern, S. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00093-4 · Cited by 215
Protein Tyrosine Kinase Inhibitors as Novel Therapeutic Agents
Levitzki, A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00066-7 · Cited by 214
Mukherjee, P., Bhattacharya, R., Bone, N., Lee, Y. K., Patra, C., Wang, S., Lu, L., Secreto, C., Banerjee, P. C., Yaszemski, M. J., et al. (2007) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-5-4 · Cited by 208
Self-citationTobita, K., Kijima, H., Dowaki, S., Kashiwagi, H., Ohtani, Y., Oida, Y., Yamazaki, H., Nakamura, M., Ueyama, Y., Tanaka, M., et al. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.11.3.305 · Cited by 204
Bhattacharya, R., Patra, C. R., Earl, A., Wang, S., Katarya, A., Lu, L., Kizhakkedathu, J. N., Yaszemski, M. J., Greipp, P. R., Mukhopadhyay, D., et al. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2007.07.001 · Cited by 200
Self-citationBurris, H. A., & Storniolo, A. M. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00324-3 · Cited by 199
Baker, C. H., Solórzano, C. C., & Fidler, I. J. (2002) · PubMed · Cited by 196
Mulloy, R., Ferrand, A., Kim, Y., Sordella, R., Bell, D. W., Haber, D. A., Anderson, K. S., & Settleman, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4293 · Cited by 192
CDKN2A Germline Mutations in Familial Pancreatic Cancer
Bartsch, D. K., Sina-Frey, M., Lang, S., Wild, A., Gerdes, B., Barth, P., Kress, R., Grützmann, R., Colombo-Benkmann, M., Ziegler, A., et al. (2002) · Annals of Surgery · doi:10.1097/00000658-200212000-00005 · Cited by 186
Tumor models for efficacy determination
Teicher, B. A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0391 · Cited by 186
Cohen, S., Fava, R. A., & Sawyer, S. T. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.20.6237 · Cited by 183
Wagener, D. J. T., Verdonk, H. E. R., Dirix, L. Y., Catimel, G., Siegenthaler, P., Buitenhuis, M., Mathieu-Boué, A., & Verweij, J. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059107 · Cited by 178
Gold in medicine: A review of its use in the west before 1900
Higby, G. J. (1982) · Gold Bulletin · doi:10.1007/bf03214618 · Cited by 176
Hidalgo, M., Castellano, D., Paz-Ares, L., Gravalos, C., Diaz-Puente, M., Hitt, R., Alonso, S., & Cortes-Funes, H. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.585 · Cited by 175
Clinical implications of the mechanism of epidermal growth factor receptor inhibitors
Marshall, J. (2006) · Cancer · doi:10.1002/cncr.22133 · Cited by 175
Boeck, S., Stieber, P., Holdenrieder, S., Wilkowski, R., & Heinemann, V. (2006) · Oncology · doi:10.1159/000094888 · Cited by 172
Yonezawa, T., & Kunitake, T. (1999) · Colloids and Surfaces A: Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(98)00309-4 · Cited by 171
Preclinical, pharmacologic, and phase I studies of gemcitabine.
Storniolo, A. M., Allerheiligen, S. R. B., & Pearce, H. L. (1997) · PubMed · Cited by 169
A multispecialty approach to the diagnosis and management of pancreatic cancer
Hawes, R. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00758-3 · Cited by 166
Magnetic Nanoparticles for Drug Delivery Applications
Namdeo, M., Saxena, S., Tankhiwale, R., Bajpai, M., Mohan, Y. M., & Bajpai, S. K. (2008) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2008.399 · Cited by 160
Gold Nanoparticles Inhibit VEGF165-Induced Proliferation of HUVEC Cells
Bhattacharya, R., Mukherjee, P., Xiong, Z., Atala, A., Soker, S., & Mukhopadhyay, D. (2004) · Nano Letters · doi:10.1021/nl0483789 · Cited by 159
Self-citationGole, A. M., Dash, C., Soman, C., Sainkar, S. R., Rao, M., & Sastry, M. (2001) · Bioconjugate Chemistry · doi:10.1021/bc0001241 · Cited by 155
Tumor Models for Efficacy Determination
Teicher, B. A. (2008) · AACR Education book · doi:10.1158/aacr.edb-mct-06-0391 · Cited by 154
Erlichman, C., Hidalgo, M. M., Boni, J. P., Martins, P., Quinn, S., Zacharchuk, C., Amorusi, P., Adjei, A. A., & Rowinsky, E. K. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.8960 · Cited by 153
The EGF Receptor System as a Target for Antitumor Therapy
Ennis, B. W., Lippman, M. E., & Dickson, R. B. (1991) · Cancer Investigation · doi:10.3109/07357909109018953 · Cited by 143
Reddy, L. H., Dubernet, C., Lepêtre‐Mouelhi, S., Marque, P. E., Desmaële, D., & Couvreur, P. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.018 · Cited by 143
A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer
Kim, E. S., Lu, C., Khuri, F. R., Tonda, M. E., Glisson, B. S., Liu, D., Jung, M., Hong, W. K., & Herbst, R. S. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00278-1 · Cited by 136
Braakhuis, B. J. M., van Dongen, G. A. M. S., Vermorken, J. B., et al. (1991) · PubMed · Cited by 135
Berger, A. C., Meszoely, I. M., Ross, E. A., Watson, J. C., & Hoffman, J. P. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.11.025 · Cited by 133
Familial melanoma, pancreatic cancer and germline CDKN2A mutations
Goldstein, A. M. (2004) · Human Mutation · doi:10.1002/humu.9247 · Cited by 130
Thermal tumour ablation: Devices, clinical applications and future directions
Haemmerich, D., & Laeseke, P. F. (2005) · International Journal of Hyperthermia · doi:10.1080/02656730500226423 · Cited by 126
Epidermal growth factor receptor-targeted therapy for pancreatic cancer
XIONG, H., & Abbruzzese, J. L. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70088-2 · Cited by 125
Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer
Lee, S. H., Ryu, J. K., Lee, K.-Y., Woo, S. M., Park, J. K., Yoo, J. W., Kim, Y., & Yoon, Y. B. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.09.015 · Cited by 116
The Incorporation of 5-Fluorouracil Into RNA and its Molecular Consequences
Mandel, H. G. (1969) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-46200-9_4 · Cited by 114
Mukherjee, P., Patra, C. R., Ghosh, A., et al. (2002) · Chemistry of Materials · doi:10.1021/cm010372m · Cited by 113
Self-citationBuchsbaum, D. J., Bonner, J. A., Grizzle, W. E., Stackhouse, M. A., Carpenter, M., Hicklin, D. J., Böhlen, P., & Raisch, K. P. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03788-4 · Cited by 113
Indian hedgehog signaling pathway: Expression and regulation in pancreatic cancer
Kayed, H., Kleeff, J. H., Keleg, S., Guo, J., Ketterer, K., Berberat, P. O., Giese, N. A., Esposito, I., Giese, T., Büchler, M. W., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20194 · Cited by 113
Niu, J., Zhu, T., & Liu, Z. (2007) · Nanotechnology · doi:10.1088/0957-4484/18/32/325607 · Cited by 110
Kinsella, A. R., Smith, D. B., & Pickard, M. R. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.164 · Cited by 107
Tassi, E., Gavazzi, F., Albarello, L., Senyukov, V., Longhi, R., Dellabona, P., Doglioni, C., Braga, M., Carlo, V. D., & Protti, M. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6595 · Cited by 107
Gold Nanoparticles Inhibit the Proliferation of Multiple Myeloma Cells
Bhattacharya, R., Patra, C. R., Verma, R., Kumar, S. K., Greipp, P. R., & Mukherjee, P. (2007) · Advanced Materials · doi:10.1002/adma.200602098 · Cited by 106
Self-citationRecent Advances on the Molecular Mechanisms Involved in Pancreatic Cancer Progression and Therapies
Mimeault, M., Brand, R. E., Sasson, A. A., & Batra, S. K. (2005) · Pancreas · doi:10.1097/01.mpa.0000175893.04660.1b · Cited by 99
Nakamoto, M., Yamamoto, M., & Fukusumi, M. (2002) · Chemical Communications · doi:10.1039/b203736j · Cited by 94
Curley, S. A., Cherukuri, P., Briggs, K. L., Patra, C. R., Upton, M., Dolson, E., & Mukherjee, P. (2008) · PubMed · Cited by 93
Self-citationSynthesis of gold nanoparticles inside polyelectrolyte brushes
Azzaroni, O., Brown, A. A., Cheng, N., Wei, A., Jonas, A. M., & Huck, W. T. S. (2007) · Journal of Materials Chemistry · doi:10.1039/b704849a · Cited by 93
Type 2 dıabetes mellıtus and CA 19-9 levels
Uygur‐Bayramiçli, O. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i40.5357 · Cited by 81
Application of Gold Nanoparticles for Targeted Therapy in Cancer
Patra, C. R., Bhattacharya, R., Mukhopadhyay, D., & Mukherjee, P. (2008) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2008.016 · Cited by 81
Self-citationCASE REPORT: Fatal Cholestatic Liver Failure Associated with Gemcitabine Therapy
Robinson, K. J., Lambiase, L. R., Li, J., Monteiro, C., & Schiff, M. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1025415616592 · Cited by 80
Growth Factor Receptors Are Differentially Expressed in Cancers of the Papilla of Vater and Pancreas
Frieß, H., Wang, L., Zhu, Z., Gerber, R., Schröder, M., Fukuda, A., Zimmermann, A., Korc, M., & Büchler, M. W. (1999) · Annals of Surgery · doi:10.1097/00000658-199912000-00005 · Cited by 79
Papamichael, D. (2000) · Stem Cells · doi:10.1634/stemcells.18-3-166 · Cited by 75
Stephan, S., Datta, K., Wang, E., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0808 · Cited by 74
Gold nanoparticles prepared by sonochemical method in thiol-functionalized ionic liquid
Jin, Y. Z., Wang, P., Yin, D., Liu, J., Liangsheng, Q., Yu, N., Guoyong, X., & Li, B. (2007) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2007.02.060 · Cited by 73
Baumann, D. (1972) · PubMed · Cited by 73
Glucagon Cell Adenomatosis: A Newly Recognized Disease of the Endocrine Pancreas
Henopp, T., Anlauf, M., Schmitt, A. M., Schlenger, R., Zalatnai, A., Couvelard, A., Ruszniewski, P. B., Schaps, K.-P., Versleijen‐Jonkers, Y. M. H., Speel, E. M., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1300 · Cited by 71
Nanoparticle Synthesis via the Photochemical Polythiol Process
Warren, S. C., Jackson, A. C., Cater-Cyker, Z. A., DiSalvo, F. J., & Wiesner, U. B. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0733639 · Cited by 71
Baumann, D. (1973) · PubMed · Cited by 71
Eye complications of cetuximab therapy
Melichar, B., & Němcová, I. (2007) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2006.00763.x · Cited by 70
Chemotherapy for pancreatic cancer
Shore, S., Raraty, M. G. T., Ghaneh, P., & Neoptolemos, J. P. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2003.01781.x · Cited by 69
Ultrasonically Induced Au Nanoprisms and Their Size Manipulation Based on Aging
Li, C., Cai, W., Li, Y., Hu, J., & Liu, P. (2006) · The Journal of Physical Chemistry B · doi:10.1021/jp055522l · Cited by 59
Orthotopic Models of Human Pancreatic Cancer
Capellá, G., Farré, L., Villanueva, A., Reyes, G., GARCÍ, C., Tarafa, G., & Lluı́s, F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09514.x · Cited by 54
A microwave-assisted polyol method for the deposition of silver nanoparticles on silica spheres
Tuval, T., & Gedanken, A. (2007) · Nanotechnology · doi:10.1088/0957-4484/18/25/255601 · Cited by 53
Tyrosine kinase inhibitors and gemcitabine: New treatment options in pancreatic cancer?
Kleespies, A., Jauch, K. ‐., & Bruns, C. J. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.02.002 · Cited by 52
Ghiorzo, P., Gargiulo, S., Pastorino, L., Nasti, S., Cusano, R., Bruno, W., Gliori, S., Sertoli, M. R., Burroni, A. G., Savarino, V., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl199 · Cited by 49
Phase II trial of ZD1694 (TomudexTM) in patients with advanced pancreatic cancer
Pazdur, R., Meropol, N. J., Casper, E. S., Fuchs, C. S., Douglass, H. O., Vincent, M. D., & Abbruzzese, J. L. (1995) · Investigational New Drugs · doi:10.1007/bf00873144 · Cited by 48
Enhanced Stability and Bioconjugation of Photo-Cross-Linked Polystyrene-Shell, Au-Core Nanoparticles
Chen, Y., Cho, J., Young, A. J., & Taton, T. A. (2007) · Langmuir · doi:10.1021/la700494e · Cited by 48
Gemcitabine-based therapy in pancreas cancer
Jacobs, A. D. (2002) · Cancer · doi:10.1002/cncr.10756 · Cited by 45
Preparation of Colloidal-Gold-Labeled Proteins
Hermanson, G. T. (1996) · Elsevier eBooks · doi:10.1016/b978-012342335-1/50015-4 · Cited by 43
Cancer in the elderly: pancreatic cancer
Shore, S., Vimalachandran, D., Raraty, M. G. T., & Ghaneh, P. (2004) · Surgical Oncology · doi:10.1016/j.suronc.2004.11.001 · Cited by 43
Mukherjee, P., Bhattacharya, R., & Mukhopadhyay, D. (2005) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2005.016 · Cited by 43
Self-citationActivated Epidermal Growth Factor Receptor as a Novel Target in Pancreatic Cancer Therapy
Gowda, H., Jimeno, A., Molina, H., Mihalas, A. B., Goggins, M., Hruban, R. H., Schulick, R. D., Kamath, U., Maitra, A., Hidalgo, M. M., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr800139r · Cited by 42
Hoekstra, R., Dumez, H., Eskens, F. A. L. M., van der Gaast, A., Planting, A. S. T., de Heus, G., Sizer, K. C., Ravera, C., Vaidyanathan, S., Bucana, C. D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0720 · Cited by 39
Zhou, J., Beattie, D. A., Sedev, R. V., & Ralston, J. (2007) · Langmuir · doi:10.1021/la700449f · Cited by 36
ANZAI, H., Kitadai, Y., Bucana, C. D., Sanchez, R. R., Omoto, R., & Fidler, I. J. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10075-2 · Cited by 35
Zapata, M., Cohen, C., & Siddiqui, M. T. (2007) · CytoJournal · doi:10.1186/1742-6413-4-13 · Cited by 32
New treatment options for advanced pancreatic cancer
Middleton, G., Ghaneh, P., Costello, E., Greenhalf, W., & Neoptolemos, J. P. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.5.673 · Cited by 31
Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
Sultana, A., Ghaneh, P., Cunningham, D., Starling, N., Neoptolemos, J. P., & Smith, C. T. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-192 · Cited by 31
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma
Casper, E. S., Schwartz, G. K., Johnson, B. E., & Kelsen, D. P. (1992) · Investigational New Drugs · doi:10.1007/bf00944187 · Cited by 21
Challenges in developing targeted therapy for pancreatic adenocarcinoma
Mahalingam, D., & Giles, F. J. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.11.1389 · Cited by 21
Fabrication of Gold Nanoparticle for Potential Application in Multiple Myeloma
Patra, C. R., Verma, R., Kumar, S. K., Greipp, P. R., Mukhopadhyay, D., & Mukherjee, P. (2008) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2008.015 · Cited by 21
Self-citationEfthimiou, E., Crnogorac‐Jurcevic, T., & Lemoine, N. R. (2001) · Pancreatology · doi:10.1159/000055865 · Cited by 20
Phase II study of amonafide in advanced pancreatic adenocarcinoma
Linke, K. A., Pazdur, R. M., Abbruzzese, J. L., et al. (1991) · Investigational New Drugs · doi:10.1007/bf00183580 · Cited by 19
Radiofrequency Ablation for Hepatic Metastasis from Gastric Adenocarcinoma
An, J. Y., Kim, J. Y., Choi, M. G., et al. (2008) · Yonsei Medical Journal · doi:10.3349/ymj.2008.49.6.1046 · Cited by 17
Functional imaging of angiogenesis in an orthotopic model of pancreatic cancer
Fleming, J. B., & Brekken, R. A. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10644 · Cited by 15
Alchemy, Chinese Versus Greek, An Etymological Approach: A Rejoinder
Mahdihassan, S. (1988) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x88000145 · Cited by 14
Is the gefitinib plus trastuzumab combination feasible in breast cancer patients?
Normanno, N., Campiglio, M., Perrone, F., Luca, A. D., & Ménard, S. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi325 · Cited by 11
Optimizing Gemcitabine Regimens in Ovarian Cancer
Pecorelli, S. L., Pasinetti, B., Tisi, G., & Odicino, F. E. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.03.014 · Cited by 6
Trastuzumab adds to adjuvant chemotherapy for resected HER2-positive breast cancer
Hudis, C. A. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0401 · Cited by 4
The EGF receptor system as a target for therapy
Normanno, N. (2008) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(08)71178-9 · Cited by 2
Cited by
Biosynthesis of Nanoparticles by Microorganisms and Their Applications
Li, X., Xu, H., Chen, Z.-S., & Chen, G. (2011) · Journal of Nanomaterials · doi:10.1155/2011/270974 · Cited by 1,133
Gold nanoparticles as novel agents for cancer therapy
Jain, S., Hirst, D. G., & O'Sullivan, J. M. (2012) · The British Journal of Radiology · doi:10.1259/bjr/59448833 · Cited by 1,059
Gold Nanoparticles for Photothermal Cancer Therapy
Vines, J. B., Yoon, J.-H., Ryu, N.-E., Lim, D.-J., & Park, H. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00167 · Cited by 906
Crossing the blood-brain barrier with nanoparticles
Zhou, Y., Peng, Z., Seven, E. S., & Leblanc, R. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.015 · Cited by 837
Wang, F., Wang, Y.-C., Dou, S., Xiong, M.-H., Sun, T.-M., & Wang, J. (2011) · ACS Nano · doi:10.1021/nn200007z · Cited by 813
Metadata
- Authors
- Patra, C. R., Bhattacharya, R., Mukhopadhyay, D., & Mukherjee, P.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 62
- Issue
- 3
- Pages
- 346-361
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2059999481
- Cited by
- 458
- References
- 194
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.